FRET-Based Membrane Receptor Binding Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for screening compounds binding to membrane receptors, particularly GPCR heterodimers, are limited by the use of radioactive substances, difficulty in high-throughput testing, and inability to distinguish between monomeric, homodimeric, and dimeric receptor binding.
Innovation Solution
A method using FRET pairs to label membrane receptors, allowing for the determination of compound binding to specific receptor forms, including R1R2 heterodimers, R1 and R2 monomers, and R1R2 homodimers, through luminescence measurements with lanthanide complexes and quenching compounds.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If radioactive labeling methods are used to determine compound binding to membrane receptors, then binding detection is achieved, but safety concerns and waste management issues arise
Solution Approach 1:
The patent replaces radioactive detection methods with fluorescence polarization technology. Instead of using radioisotopes to label compounds and measure binding through radiation detection, the invention uses fluorescently labeled compounds and measures polarization changes in emitted light. This substitution eliminates safety hazards associated with radioactive materials while maintaining the ability to detect compound-receptor binding events.
2Measurement precision
If classic radioactive binding assays are used, then compound binding can be measured, but high-throughput screening becomes difficult
Solution Approach 1:
The invention replaces cumbersome radioactive assay procedures with fluorescence polarization measurements that are inherently more amenable to automation. The fluorescent labeling approach allows for simpler protocol steps, reduced handling time, and easier integration into automated liquid handling systems, thereby enabling high-throughput screening of large compound libraries while maintaining accurate binding measurements.
3Measurement precision
If conventional binding assays are used, then compound binding is detected, but information about receptor dimerization state is lost
Solution Approach 1:
The patent applies segmentation by separately analyzing binding data from monomeric and dimeric receptor populations. By using fluorescence polarization in conjunction with appropriate controls and analytical methods, the invention can distinguish and quantify binding events specific to monomers versus dimers, thereby preserving information about receptor dimerization state that would be lost in conventional bulk binding assays.
4Object-affected harmful factors
If fluorescent labeling methods are used instead of radioactive methods, then safety issues are reduced, but the ability to distinguish between different receptor forms is limited
Solution Approach 1:
The patent overcomes the limitation of fluorescent methods by implementing a segmented analysis approach. Through careful experimental design including the use of selective ligands, appropriate controls, and data analysis methods, the invention can resolve and distinguish binding signals from monomeric and dimeric receptor forms separately, thereby maintaining the ability to discriminate between different receptor forms while benefiting from the safety advantages of fluorescent labeling.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise identification of compound binding to various receptor forms, facilitating the screening of compounds for their specificity to different receptor dimerization states without the need for radioactive materials, and is applicable on high-throughput platforms.
Implementation Method 1
The invention uses FRET pairs to label membrane receptors, allowing for the determination of compound binding to specific receptor forms, including R1R2 heterodimers, R1 and R2 monomers, and R1R2 homodimers, through luminescence measurements with lanthanide complexes
Implementation Method 2
The invention uses FRET pairs to label membrane receptors, allowing for the determination of compound binding to specific receptor forms, including R1R2 heterodimers, R1 and R2 monomers, and R1R2 homodimers, through luminescence measurements with lanthanide complexes and quenching compounds
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention relates to a method that makes it possible to predetermine if a compound to be tested preferably binds to a membrane receptor R1 or to a membrane receptor R2, said receptors being known to be expressed as a monomeric, homodimeric, or heterodimeric receptor on the surface of cells. Said method is implemented through the use of one or two FRET partner pairs.